Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by StockReddyon Aug 07, 2020 8:24pm
153 Views
Post# 31381645

RE:RE:Buying rights offer was my mistake

RE:RE:Buying rights offer was my mistakeThey may do, what if they go for dilution before BLA submission. I am so confused and I cannot believe them anymore. 

BLA submission is good news, right? Why they want to submit BLA after delisting from TSX? If it is good news it will be rewarded in TSX as well.

 It is suspicious to me. My guess dilution is first BLA submission is later.

Good Luck for longs!

<< Previous
Bullboard Posts
Next >>